Top Suppliers:I want be here




85650-52-8

85650-52-8 structure
85650-52-8 structure
  • Name: Mirtazapine
  • Chemical Name: Mirtazapine
  • CAS Number: 85650-52-8
  • Molecular Formula: C17H19N3
  • Molecular Weight: 265.353
  • Catalog: Biochemical Inhibitor Neuronal Signaling 5-HT Receptor Antagonist
  • Create Date: 2018-09-08 11:52:06
  • Modify Date: 2024-01-02 16:31:30
  • Mirtazapine is a potent tetracyclic antidepressant.Target: 5-HT ReceptorMirtazapine, the novel antidepressant, has a dual mode of action. It is a noradrenergic and specific serotonergic antidepressant (NaSSA) that acts by antagonizing the adrenergic alpha2-autoreceptors and alpha2-heteroreceptors as well as by blocking 5-HT2 and 5-HT3 receptors [1].Mirtazapine appears to have a substantial ameliorating effect on hot flushes and perspiration bouts. It is postulated that the 5-HT(2A) blocking properties of mirtazapine is accounted in the symptomatic relief of hot flushes [2]. After 4-24 weeks of treatment, mirtazapine induced downregulation of platelet alpha(2A)-adrenoceptors (up to 34%) and Galphai proteins (up to 28%), and the upregulation of GRK 2 (up to 30%). Treatment with mirtazapine reversed this abnormality and induced downregulation of alpha(2A)-adrenoceptor/Galphai complex [3].

Name Mirtazapine
Synonyms Pyrazino[2,1-a]pyrido[2,3-c][2]benzazepine, 1,2,3,4,10,14b-hexahydro-2-methyl-
Zispin
(14bR)-2-methyl-1,2,3,4,10,14b-hexahydropyrazino[2,1-a]pyrido[2,3-c][2]benzazepine
1,2,3,4,10,14B-HEXAHYDRO-2-METHYLPYRAZINO[2.1-A]PYRIDO[2.3-C][2]BENZAZEPINE
Mirtazapin
1,2,3,4,10,14B-HEXAHYDRO-2-METHYLPYRAZINO[2,1-A]PYRIDO[2,3-C][2]BENZAZEPINE
Remeron
ORG-3770
UNII:A051Q2099Q
2-Methyl-1,2,3,4,10,14b-hexahydropyrazino[2,1-a]pyrido[2,3-c][2]benzazepine
MIRTAZEPINE
2-Methyl-1,2,3,4,10,14b-hexahydrobenzo[c]pyrazino[1,2-a]pyrido[3,2-f]azepine
Mirtazanine
Avanza
MFCD00865427
MIRTAZAPINE ANHYDRUOS
EINECS 288-060-6
Description Mirtazapine is a potent tetracyclic antidepressant.Target: 5-HT ReceptorMirtazapine, the novel antidepressant, has a dual mode of action. It is a noradrenergic and specific serotonergic antidepressant (NaSSA) that acts by antagonizing the adrenergic alpha2-autoreceptors and alpha2-heteroreceptors as well as by blocking 5-HT2 and 5-HT3 receptors [1].Mirtazapine appears to have a substantial ameliorating effect on hot flushes and perspiration bouts. It is postulated that the 5-HT(2A) blocking properties of mirtazapine is accounted in the symptomatic relief of hot flushes [2]. After 4-24 weeks of treatment, mirtazapine induced downregulation of platelet alpha(2A)-adrenoceptors (up to 34%) and Galphai proteins (up to 28%), and the upregulation of GRK 2 (up to 30%). Treatment with mirtazapine reversed this abnormality and induced downregulation of alpha(2A)-adrenoceptor/Galphai complex [3].
Related Catalog
References

[1]. Anttila, S.A. and E.V. Leinonen, A review of the pharmacological and clinical profile of mirtazapine. CNS Drug Rev, 2001. 7(3): p. 249-64.

[2]. Waldinger, M.D., H.H. Berendsen, and D.H. Schweitzer, Treatment of hot flushes with mirtazapine: four case reports. Maturitas, 2000. 36(3): p. 165-8.

[3]. Garcia-Sevilla, J.A., et al., Regulation of platelet alpha 2A-adrenoceptors, Gi proteins and receptor kinases in major depression: effects of mirtazapine treatment. Neuropsychopharmacology, 2004. 29(3): p. 580-8.

Density 1.2±0.1 g/cm3
Boiling Point 432.4±45.0 °C at 760 mmHg
Melting Point 114-116ºC
Molecular Formula C17H19N3
Molecular Weight 265.353
Flash Point 215.3±28.7 °C
Exact Mass 265.157898
PSA 19.37000
LogP 2.75
Vapour Pressure 0.0±1.0 mmHg at 25°C
Index of Refraction 1.668
Storage condition Store at RT
Water Solubility DMSO: ~8 mg/mL, soluble
Symbol GHS07
GHS07
Signal Word Warning
Hazard Statements H302-H336
Precautionary Statements P301 + P312 + P330
Personal Protective Equipment Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
Hazard Codes Xn
Risk Phrases 22
Safety Phrases S22-S24/25
RIDADR NONH for all modes of transport
WGK Germany 3
HS Code 2933990090

~94%

85650-52-8 structure

85650-52-8

Literature: Singer, Claude; Liberman, Anita; Finkelstein, Nina Patent: US2001/51718 A1, 2001 ; Title/Abstract Full Text Show Details Singer, Claude; Liberman, Anita; Finkelstein, Nina Patent: US2003/69417 A1, 2003 ;

~82%

85650-52-8 structure

85650-52-8

Literature: N.V. ORGANON Patent: WO2008/125578 A2, 2008 ; Location in patent: Page/Page column 16 ;

~55%

85650-52-8 structure

85650-52-8

Literature: N.V. Organon Patent: US2008/255349 A1, 2008 ; Location in patent: Page/Page column 9 ;

~%

85650-52-8 structure

85650-52-8

Literature: WO2008/125577 A1, ; Page/Page column 22 ;

~%

85650-52-8 structure

85650-52-8

Literature: Organic Preparations and Procedures International, , vol. 39, # 4 p. 399 - 402

~%

85650-52-8 structure

85650-52-8

Literature: Organic Preparations and Procedures International, , vol. 39, # 4 p. 399 - 402

~%

85650-52-8 structure

85650-52-8

Literature: Organic Preparations and Procedures International, , vol. 39, # 4 p. 399 - 402

~%

85650-52-8 structure

85650-52-8

Literature: Organic Preparations and Procedures International, , vol. 39, # 4 p. 399 - 402
HS Code 2933990090
Summary 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%